MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • MDS Virtual Congress 2021

    Effects of safinamide adjunct therapy on non-motor symptoms in patients with Parkinson’s disease: a post-hoc analysis of the Japanese Phase 2/3 study

    N. Hattori, Y. Tsuboi, Y. Kogo, M. Koebisu, T. Ishida, I. Suzuki, M. Nomoto (Tokyo, Japan)

    Objective: To evaluate the efficacy of safinamide for mood and pain by a post-hoc analysis of the Japanese phase 2/3 double-blind study (JapicCTI-153056) in patients…
  • MDS Virtual Congress 2021

    Mood is a Key Factor in Progression of Non-Motor Symptoms Burden in Parkinson´s disease.

    D. Santos García, C. Cores, T. de Deus, J. Paz González, C. Martínez, E. Suárez, S. Jesús, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, M. Catalán, V. Nogueira, V. Puente, J. García Moreno, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, J. Martínez Castrillo, P. Sánchez Alonso, G. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Blázquez, M. Seijo, J. Ruíz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González, C. Ordás, L. López Díaz, P. Mir, P. Martínez Martín, C. Coppadis (A Coruña, Spain)

    Objective: The aim of the present study was to identify predictors of non-motor symptoms burden non-progression (NMSB-NP) in PD patients from a Spanish cohort  [1,2].…
  • MDS Virtual Congress 2021

    Safinamide Improves Mood in Parkinson´s Disease. Results from the SAFINONMOTOR Study.

    C. Labandeira, MG. Alonso Losada, R. Yáñez Baña, I. Cimas Hernando, I. Cabo López, JM. Paz González, MJ. González Palmás, C. Martínez Miró, D. Santos García (Vigo, Spain)

    Objective: Our aim was to analyze the effectiveness of safinamide on mood in Parkinson´s disease (PD) patients from the SAFINONMOTOR (an open-label study of the…
  • MDS Virtual Congress 2021

    Evidence of Overlapping Pathology between Depression and Autonomic Dysfunction in Parkinson’s Disease

    M. Sklerov, E. Dayan, N. Browner, D. Rubinow, F. Frohlich (Chapel Hill, USA)

    Objective: To investigate the association between symptoms of depression and symptoms of autonomic dysfunction (AuD) in people with Parkinson’s disease (PD). Background: Depression and AuD…
  • MDS Virtual Congress 2021

    Fatigue in patients with progressive supranuclear palsy

    JH. Ahn, J. Song, I. Choi, DY. Lee, J. Youn, JW. Cho (Seoul, Republic of Korea)

    Objective: To investigate prevalence and clinical impact of fatigue in the patients with progressive supranuclear palsy Background: Fatigue is a common and disabling non-motor symptom…
  • MDS Virtual Congress 2021

    THE ASSOCIATION OF ANXIETY AND DEPRESSION WITH TREMORS IN PARKINSON’S DISEASE PATIENTS

    F. Susanti, C. Arina, H. Hutagalung (Medan, Indonesia)

    Objective: To determine the relation between anxiety and depression with tremors in patients with PD so that it can be possible to detect the symptoms…
  • MDS Virtual Congress 2021

    Investigation of the consultation status and clinical symptoms of patients with Parkinson’s disease after the spread of COVID-19

    M. Iijima, R. Morimoto, K. Kitagawa (Tokyo, Japan)

    Objective: This study investigated the consultation status and clinical symptoms of patients with Parkinson’s disease (PD) after the coronavirus disease 2019 (COVID-19) pandemic. Background: Due…
  • MDS Virtual Congress 2021

    Social support moderates the burden of nonmotor but not motor symptoms among patients with Parkinson’s disease

    HJ. Yang, A. Kim, BS. Park (Ulsan, Republic of Korea)

    Objective: The present study tested the extent of moderating effects of patient-perceived social support on the association between motor and nonmotor symptoms and Health-related quality…
  • MDS Virtual Congress 2021

    Prevalence of Suicidal Ideation and Associated Clinical Features in Lewy Body Dementia

    K. Moore, M. Armstrong, C. Jacobson, N. Gamez, B. Patel, J. Sullivan (Gainesville, USA)

    Objective: The goal of this study was to identify the prevalence of suicidal ideation (SI) in Lewy body dementia (LBD) and the factors associated with…
  • MDS Virtual Congress 2021

    Using smartphone data to infer social behaviour in Parkinson’s: proof of principle and the impact of COVID19

    H. Zhang, E. Poliakoff, B. Parsia, S. Harper (Manchester, United Kingdom)

    Objective: To investigate the potential of using smartphone data to infer changes in social behaviour in people with Parkinson's and how this has been impacted…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley